Role of JNK and NF-κB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cells
- 10 September 2015
- journal article
- research article
- Published by Springer Nature in Cellular Oncology
- Vol. 38 (6) , 463-478
Abstract
The 4,5-diarylimidazole brimamin is an analog of the natural vascular-disrupting agent combretastatin A-4 (CA-4) with improved water solubility, tolerance by animals and efficacy in multidrug-resistant tumors. Here, we aimed at identifying the major mechanisms underlying the in vitro and in vivo actions of brimamin on endothelial and carcinoma cells, including vascularization.Keywords
This publication has 60 references indexed in Scilit:
- Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 inductionMolecular Biology of the Cell, 2012
- A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cellsBlood, 2011
- c-Jun N-terminal Kinase Phosphorylation of Stathmin Confers Protection against Cellular StressJournal of Biological Chemistry, 2010
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDFCancer Research, 2010
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerBritish Journal of Cancer, 2010
- Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65Journal of Biological Chemistry, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologiesInternational Journal of Experimental Pathology, 2009
- A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with OutcomeThyroid®, 2009
- Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2Nature Cell Biology, 2007